Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,420 | 700 | 1,150 | 1,500 | 1,460 |
| TOTAL | $1,420 | $700 | $1,150 | $1,500 | $1,460 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 6,970 | 7,070 | 7,160 | 7,260 | 7,840 |
| TOTAL | $6,970 | $7,070 | $7,160 | $7,260 | $7,840 |
| Total Assets | $8,390 | $7,770 | $8,310 | $8,760 | $9,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 2,290 | 2,290 | 0 | 0 |
| Accounts payable and accrued liabilities | 6,160 | 6,130 | 5,150 | 7,640 | 5,580 |
| Other current liabilities | 10 | 1,100 | 390 | 2,690 | 2,320 |
| TOTAL | $6,170 | $9,520 | $7,830 | $10,330 | $7,900 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,860 | 30 | 40 | 40 | 150 |
| TOTAL | $2,860 | $30 | $40 | $40 | $150 |
| Total Liabilities | $9,030 | $9,550 | $7,870 | $10,370 | $8,050 |
| Shareholders' Equity | |||||
| Common Shares | 180 | 650 | 150 | 150 | 150 |
| Other shareholders' equity | -720 | -790 | 60 | 0 | 0 |
| TOTAL | $437,540 | $427,080 | $426,550 | $426,300 | $425,780 |
| Total Liabilities And Equity | $446,570 | $436,630 | $434,420 | $436,670 | $433,830 |